An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.
Vanderbilt biochemists got unexpected results when they used their new approach to explore the role of DNA methylation in gene regulation.
Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
Accessibility Tools